Silver Spring, Maryland—(ENEWSPF)—June 25, 2018
Contacts: Michael Felberbaum and Sandy Walsh
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that…
